|

Gut Microbiota in the Progression of Alpha-synucleinopathies

RECRUITINGSponsored by Chinese University of Hong Kong
Actively Recruiting
SponsorChinese University of Hong Kong
Started2022-02-01
Est. completion2024-06-30
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05353868

Summary

The aim of this study is to correlate baseline gut microbiota features and the progression of neurodegeneration in the established cohort of patients with early Parkinson's disease.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* recruit from the subjects who completed the baseline study

Exclusion Criteria:

* The use of probiotics or antibiotics within three months prior to sample collection;
* Pre-existing gastrointestinal diseases, such as inflammatory bowel disease.
* Not capable of giving informed consent for participation of the study.

Conditions2

Parkinson's DiseaseREM Sleep Behavior Disorder

Browse More Trials

Parkinson's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.